Biomarkers in clinical trials: Can we move from fortune telling to disease profiling?

James A de Lemos; Darren K McGuire

doi:10.1161/CIRCULATIONAHA.111.044271

Biomarkers in clinical trials: Can we move from fortune telling to disease profiling?

Research output: Contribution to journal › Review article › peer-review

Original language	English (US)
Pages (from-to)	663-665
Number of pages	3
Journal	Circulation
Volume	124
Issue number	6
DOIs	https://doi.org/10.1161/CIRCULATIONAHA.111.044271
State	Published - Aug 9 2011

ASJC Scopus subject areas

Cardiology and Cardiovascular Medicine
Physiology (medical)

Access to Document

10.1161/CIRCULATIONAHA.111.044271

Cite this

@article{601a985e8c20480896206fd5fcba99d1,

title = "Biomarkers in clinical trials: Can we move from fortune telling to disease profiling?",

author = "{de Lemos}, {James A} and McGuire, {Darren K}",

year = "2011",

month = aug,

day = "9",

doi = "10.1161/CIRCULATIONAHA.111.044271",

language = "English (US)",

volume = "124",

pages = "663--665",

journal = "Circulation",

issn = "0009-7322",

publisher = "Lippincott Williams and Wilkins",

number = "6",

}

TY - JOUR

T1 - Biomarkers in clinical trials

T2 - Can we move from fortune telling to disease profiling?

AU - de Lemos, James A

AU - McGuire, Darren K

PY - 2011/8/9

Y1 - 2011/8/9

UR - http://www.scopus.com/inward/record.url?scp=80051737053&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=80051737053&partnerID=8YFLogxK

U2 - 10.1161/CIRCULATIONAHA.111.044271

DO - 10.1161/CIRCULATIONAHA.111.044271

M3 - Review article

C2 - 21824932

AN - SCOPUS:80051737053

VL - 124

SP - 663

EP - 665

JO - Circulation

JF - Circulation

SN - 0009-7322

IS - 6

ER -

Biomarkers in clinical trials: Can we move from fortune telling to disease profiling?

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this